New drug reform likely to have restrictive impacts to domestic pharmaceutical sector

Published: 2013-09-24 06:58:00

Updated: 2013-09-24 06:58:00

The Ministry of Health and Welfare has recently announced a major overhaul of the national health insurance program to broaden coverage of expenses related to the so-called four major illnesses designated by the Park Geun-hye government and readjust the prices of expensive drugs In Korea.

The...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK